Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C?

G Ippolito; A Zumla; S Lanini

doi:10.1016/j.cmi.2018.01.001

Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C?

Clin Microbiol Infect. 2018 Apr;24(4):328-331. doi: 10.1016/j.cmi.2018.01.001. Epub 2018 Jan 8.

Authors

G Ippolito¹, A Zumla², S Lanini³

Affiliations

¹ National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy. Electronic address: giuseppe.ippolito@inmi.it.
² Division of Infection and Immunity, University College London, NIHR Biomedical Research Centre at UCL Hospitals NHS Foundation Trust, London, United Kingdom.
³ National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

PMID: 29326009
DOI: 10.1016/j.cmi.2018.01.001

No abstract available

Keywords: Direct-acting antivirals for chronic hepatitis C; Evidence-based medicine; Hepatitis C; Hepatocellular carcinoma; Meta-analysis; Observational study; Outcome research; Randomized controlled study; Sustained virologic response.

Publication types

Historical Article
Letter
Meta-Analysis
Review

MeSH terms

Disease Management
Hepacivirus* / genetics
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / diagnosis
Hepatitis C, Chronic / therapy
Hepatitis C, Chronic / virology*
History, 20th Century
History, 21st Century
Humans
Research* / history